Iradimed (IRMD) Net Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 343.24% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 19.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 20.59% |
| Sep 30, 2025 | 17.62% |
| Jun 30, 2025 | 21.23% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | 9.76% |
| Sep 30, 2024 | 25.15% |
| Jun 30, 2024 | 49.40% |
| Mar 31, 2024 | 43.95% |
| Dec 31, 2023 | 69.75% |
| Sep 30, 2023 | 67.69% |
| Jun 30, 2023 | 58.46% |
| Mar 31, 2023 | 24.40% |
| Dec 31, 2022 | 4.26% |
| Sep 30, 2022 | 11.76% |
| Jun 30, 2022 | 15.77% |
| Mar 31, 2022 | 10.45% |
| Dec 31, 2021 | 31.62% |
| Sep 30, 2021 | 2.39% |
| Jun 30, 2021 | 2.75% |
| Mar 31, 2021 | 18.13% |
| Dec 31, 2020 | 51.41% |
| Sep 30, 2020 | 77.43% |
| Jun 30, 2020 | -99.29% |
| Mar 31, 2020 | 112.40% |
| Dec 31, 2019 | 78.51% |
| Sep 30, 2019 | 16.30% |
| Jun 30, 2019 | -2.17% |
| Mar 31, 2019 | -6.83% |
| Dec 31, 2018 | -10.79% |
| Sep 30, 2018 | 8.73% |
| Jun 30, 2018 | -8.53% |
| Mar 31, 2018 | -17.30% |
| Dec 31, 2017 | 21.04% |
| Sep 30, 2017 | -6.76% |
| Jun 30, 2017 | -29.50% |
| Mar 31, 2017 | -34.73% |
| Dec 31, 2016 | 6.34% |
| Sep 30, 2016 | 81.57% |
| Jun 30, 2016 | 58.69% |